journal article·2021

Hybrid system {W 6 I 8 }-cluster/dsDNA as an agent for targeted X-ray induced photodynamic therapy of cancer stem cells

Tatiana N. Pozmogova, Natalya A. Sitnikova, Ekaterina V. Pronina, Svetlana M. Miroshnichenko, Andrey O. Kushnarenko, Anastasiya O. Solovieva, Sergey S. Bogachev, Georgy D. Vavilov, Olga A. Efremova, Yuri A. Vorotnikov, Michael A. Shestopalov

Materials Chemistry Frontiers· Volume 5· Issue 20
Publisher page

Abstract

The hybrid material W 6 -cluster/dsDNA designed here demonstrates selective penetration into cancer stem cells and their targeted elimination using X-PDT.
Only a short abstract or summary was supplied by the source.
Source: crossref · Quality: short

Research context

OpenAlex topics: Inorganic Chemistry and Materials · Nanoplatforms for cancer theranostics · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Institute of Clinical and Experimental Lymphology – Branch of the ICG SB RAS, 2 Timakova st., 630060 Novosibirsk, Russian Federation

Novosibirsk State University, 2 Pirogova st., 630090 Novosibirsk, Russian Federation

Nikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., 630090 Novosibirsk, Russian Federation

Federal Research Centre for Basic and Translational Medicine, 2 Timakova st., 630060 Novosibirsk, Russian Federation

Institute of Cytology and Genetics, SB RAS, 10 Acad. Lavrentiev Ave., 630090 Novosibirsk, Russian Federation

National Medical Research Center for Circulation Pathology n.a. Academician E.N. Meshalkin, 15 Rechkunovskaya st., 630055 Novosibirsk, Russian Federation

Funding

Russian Science Foundation · Russian Foundation for Basic Research · Ministry of Education and Science of the Russian Federation

References (42)

Show source-provided references
1. World Health Organization, Cancer, ( https://www.who.int/news-room/fact-sheets/detail/cancer )
2. World Cancer Report 2014, World Health Organization, Geneva, Switzerland, 2014
3. Fares · Signal Transduction Targeted Ther. · 2020 · 5 · 2810.1038/s41392-020-0134-x ↗
4. Tarin · Semin. Cancer Biol. · 2011 · 21 · 7210.1016/j.semcancer.2010.12.006 ↗
5. Bacac · Annu. Rev. Pathol. · 2008 · 3 · 22110.1146/annurev.pathmechdis.3.121806.151523 ↗
6. Dagogo-Jack · Nat. Rev. Clin. Oncol. · 2018 · 15 · 8110.1038/nrclinonc.2017.166 ↗
7. Rich · Medicine · 2016 · 95 · e4764
8. Al-Hajj · Oncogene · 2004 · 23 · 727410.1038/sj.onc.1207947 ↗
9. Kreso · Cell Stem Cell · 2014 · 14 · 27510.1016/j.stem.2014.02.006 ↗
10. Yang · Signal Transduction Targeted Ther. · 2020 · 5 · 810.1038/s41392-020-0110-5 ↗
11. Shackleton · Cell · 2009 · 138 · 82210.1016/j.cell.2009.08.017 ↗
12. Atashzar · J. Cell. Physiol. · 2020 · 235 · 79010.1002/jcp.29044 ↗
13. Bonnet · Nat. Med. · 1997 · 3 · 73010.1038/nm0797-730 ↗
14. Reya · Nature · 2001 · 414 · 10510.1038/35102167 ↗
15. Baldo · OncoImmunology · 2013 · 2 · e2633310.4161/onci.26333 ↗
16. Radiotherapy in Cancer Care: Facing the Global Challenge, International atomic energy agency, Vienna, 2017
17. Svezhentseva · Chem. – Eur. J. · 2018 · 24 · 1791510.1002/chem.201804663 ↗
18. Evtushok · Dalton Trans. · 2017 · 46 · 1173810.1039/C7DT01919J ↗
19. Petunin · Eur. J. Inorg. Chem. · 2020 · 217710.1002/ejic.202000204 ↗
20. Bregnhoj · J. Phys. Chem. A · 2019 · 123 · 173010.1021/acs.jpca.9b00541 ↗
21. Fuhrmann · Eur. J. Inorg. Chem. · 2017 · 425910.1002/ejic.201700763 ↗
22. Jackson · J. Phys. Chem. · 1990 · 94 · 450010.1021/j100374a029 ↗
23. Riehl · Dalton Trans. · 2016 · 45 · 1550010.1039/C6DT02471H ↗
24. Zhao · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2020 · 12 · e1583
25. Yang · Nano Lett. · 2019 · 19 · 182110.1021/acs.nanolett.8b04875 ↗
26. Cao · Chem. Commun. · 2021 · 57 · 224510.1039/D0CC08219H ↗
27. Cao · Angew. Chem., Int. Ed. · 2018 · 57 · 775910.1002/anie.201802497 ↗
28. Shi · Nanomedicine · 2019 · 14 · 202710.2217/nnm-2019-0094 ↗
29. Kirakci · Inorg. Chem. · 2016 · 55 · 80310.1021/acs.inorgchem.5b02282 ↗
30. Ivanov · Inorg. Chem. Front. · 2019 · 6 · 88210.1039/C8QI01216D ↗
31. Kirakci · Biomater. Sci. · 2021 · 9 · 289310.1039/D0BM02005B ↗
32. Kirakci · J. Mater. Chem. B · 2018 · 6 · 430110.1039/C8TB00893K ↗
33. Dolgova · Stem Cell Res. Ther. · 2016 · 7 · 710.1186/s13287-016-0338-8 ↗
34. Dolgova · Cancer Biol. Ther. · 2014 · 15 · 137810.4161/cbt.29854 ↗
35. Potter · OncoTarget · 2016 · 7 · 1158010.18632/oncotarget.7311 ↗
36. Alivisatos · Nature · 1996 · 382 · 60910.1038/382609a0 ↗
37. Mirkin · Nature · 1996 · 382 · 60710.1038/382607a0 ↗
38. Mornet · Mater. Lett. · 2000 · 42 · 18310.1016/S0167-577X(99)00181-0 ↗
39. Abrescia · Nucleic Acids Res. · 1999 · 27 · 159310.1093/nar/27.7.1593 ↗
40. Lee · J. Biol. Chem. · 1999 · 274 · 1979210.1074/jbc.274.28.19792 ↗
41. This is a dose calculated for full body irradiation of human and does not correspond to a real dose absorbed by investigated cells, which is much smaller. We used Monitor Units (MU); 1 MU = 1 cGy at a depth of 10 cm in water. Cells were on the bottom of a cuvette, in a monolayer of approximately 10 μm thickness, under a 1 cm layer of the medium. The dose calculated for humans equals approximately to 120 Gy
42. R. G. Hawley , A. Ramezani and T. S. Hawley , in Methods in Enzymology , ed. I. Klimanskaya and R. Lanza , Academic Press , USA , 2006 , vol. 419, pp. 149–179